2006
DOI: 10.5796/electrochemistry.74.156
|View full text |Cite
|
Sign up to set email alerts
|

Detection of C-Reactive Protein in Serum Using Resonant Property of Quartz Crystal Microbalance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…At present, sensors that use a quartz crystal microbalance [1][2][3][4][5] or surface plasmon resonance phenomena [6][7][8][9][10] have been reported as methods for successful detection of biomarkers. The former has successfully detected C-reactive protein (CRP), which is a biomarker of cardiovascular disease, in 2006 [5], and the latter has detected a prostate specific antigen (PSA), known to be a cancer marker, from 2004 to 2008 [6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…At present, sensors that use a quartz crystal microbalance [1][2][3][4][5] or surface plasmon resonance phenomena [6][7][8][9][10] have been reported as methods for successful detection of biomarkers. The former has successfully detected C-reactive protein (CRP), which is a biomarker of cardiovascular disease, in 2006 [5], and the latter has detected a prostate specific antigen (PSA), known to be a cancer marker, from 2004 to 2008 [6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…At present, sensors that use a quartz crystal microbalance [1][2][3][4][5] or surface plasmon resonance phenomena [6][7][8][9][10] have been reported as methods for successful detection of biomarkers. The former has successfully detected C-reactive protein (CRP), which is a biomarker of cardiovascular disease, in 2006 [5], and the latter has detected a prostate specific antigen (PSA), known to be a cancer marker, from 2004 to 2008 [6][7][8][9][10]. However, because these sensors use bulk quartz or prisms, it is difficult to simultaneously detect multiple types of biomarkers on one sensor chip, and it becomes expensive to examine because the amount of antibody reagent required for one measurement increases.…”
Section: Introductionmentioning
confidence: 99%